Compare · SNX vs WGS
SNX vs WGS
Side-by-side comparison of TD SYNNEX Corporation (SNX) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SNX and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- SNX is the larger of the two at $20.35B, about 9.7x WGS ($2.09B).
- Over the past year, SNX is up 61.2% and WGS is down 47.2% - SNX leads by 108.4 points.
- SNX has been more active in the news (17 items in the past 4 weeks vs 2 for WGS).
- SNX has more recent analyst coverage (22 ratings vs 8 for WGS).
- Company
- TD SYNNEX Corporation
- GeneDx Holdings Corp.
- Price
- -
- -
- Market cap
- $20.35B
- $2.09B
- 1M return
- -6.62%
- -39.26%
- 1Y return
- +61.19%
- -47.20%
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2003
- 2020
- News (4w)
- 17
- 2
- Recent ratings
- 22
- 8
TD SYNNEX Corporation
SYNNEX Corporation provides business process services in the United States and internationally. The company distributes peripherals; and information technology systems, including system components, software, networking, communications and security equipment, consumer electronics, and complementary products, as well as designs and integrates data center equipment. It also provides systems design and integration solutions, build-to-order, and configure-to-order assembly capabilities; logistics services that comprise outsourced fulfillment, virtual distribution, and direct ship to end-users; cloud services; online services; and financing services comprising net terms, third party leasing, floor plan financing, and letters of credit backed financing and arrangements. In addition, the company offers marketing services, such as direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves resellers, system integrators, and retailers. The company was formerly known as SYNNEX Information Technologies, Inc. and changed its name to SYNNEX Corporation in October 2003. SYNNEX Corporation was founded in 1980 and is headquartered in Fremont, California.
Latest SNX
- SEC Form 4 filed by TD SYNNEX Corporation
- TD SYNNEX Launches Space Tech Initiative to Help Partners Capitalize on the Growing Space Economy
- TD SYNNEX Unveils AI That Works Alongside Partners, Expanding PartnerFirst with Agentic Capabilities
- TD SYNNEX Introduces FinOps Fusion to Optimize AI Token Spend Across Cloud and Core Infrastructure
- TD SYNNEX Announces Entering Into a Definitive Agreement to Acquire BlueStar
- SEC Form 4 filed by TD SYNNEX Corporation
- SEC Form 4 filed by TD SYNNEX Corporation
- SEC Form 4 filed by TD SYNNEX Corporation
- SEC Form 4 filed by TD SYNNEX Corporation
- SEC Form 4 filed by TD SYNNEX Corporation
Latest WGS
- GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
- GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)
- Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $310,932 worth of shares (3,692 units at $84.22), increasing direct ownership by 3% to 107,227 units (SEC Form 4) to cover taxes
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $108,220 worth of shares (1,285 units at $84.22), increasing direct ownership by 3% to 41,476 units (SEC Form 4) to satisfy tax liability
- GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $31,188 worth of shares (372 units at $83.84), increasing direct ownership by 0.86% to 40,299 units (SEC Form 4) to cover taxes
- SEC Form 144 filed by GeneDx Holdings Corp.